Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FUXS6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,101
Award facts
- Contract value 100% obligated
- $64,101.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $64,101.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on April 10, 2025, with completion targeted for April 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, making this delivery order part of the federal government's pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this prime IDC to supply an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. The contractor's consistent receipt of competitively awarded delivery orders demonstrates its established capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FUXS6?
SPE2DB25FUXS6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 10, 2025.
How much is contract SPE2DB25FUXS6 worth?
The government has obligated $64,101 on SPE2DB25FUXS6.
Is contract SPE2DB25FUXS6 an order under another contract?
Yes. SPE2DB25FUXS6 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FUXS6 competed?
The extent of competition for SPE2DB25FUXS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award